학술논문

An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014–2017
Document Type
Article
Source
In: Multiple Sclerosis and Related Disorders. (Multiple Sclerosis and Related Disorders, November 2020, 46)
Subject
Language
English
ISSN
22110356
22110348